These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 24059236

  • 41. Is there a role for antiinflammatory treatment in COPD?
    Beeh KM, Glaab T.
    COPD; 2009 Oct; 6(5):395-403. PubMed ID: 19863369
    [Abstract] [Full Text] [Related]

  • 42. New anti-inflammatory targets for chronic obstructive pulmonary disease.
    Barnes PJ.
    Nat Rev Drug Discov; 2013 Jul; 12(7):543-59. PubMed ID: 23977698
    [Abstract] [Full Text] [Related]

  • 43. Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease.
    Hardaker EL, Bacon AM, Carlson K, Roshak AK, Foley JJ, Schmidt DB, Buckley PT, Comegys M, Panettieri RA, Sarau HM, Belmonte KE.
    FASEB J; 2004 Jan; 18(1):191-3. PubMed ID: 14597565
    [Abstract] [Full Text] [Related]

  • 44. The cytokine network in chronic obstructive pulmonary disease.
    Barnes PJ.
    Am J Respir Cell Mol Biol; 2009 Dec; 41(6):631-8. PubMed ID: 19717810
    [Abstract] [Full Text] [Related]

  • 45. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
    Knobloch J, Wahl C, Feldmann M, Jungck D, Strauch J, Stoelben E, Koch A.
    Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):202-9. PubMed ID: 23981542
    [Abstract] [Full Text] [Related]

  • 46. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
    Costa C, Rufino R, Traves SL, Lapa E Silva JR, Barnes PJ, Donnelly LE.
    Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
    [Abstract] [Full Text] [Related]

  • 47. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z, Koch AE, Tak PP.
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [Abstract] [Full Text] [Related]

  • 48. Chemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte trafficking.
    Tomankova T, Kriegova E, Liu M.
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr 01; 308(7):L603-18. PubMed ID: 25637606
    [Abstract] [Full Text] [Related]

  • 49. Chemokines.
    Horuk R.
    ScientificWorldJournal; 2007 Feb 19; 7():224-32. PubMed ID: 17334613
    [Abstract] [Full Text] [Related]

  • 50. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO, de Jager SC, van Berkel TJ, Biessen EA, Jukema JW.
    Curr Pharm Des; 2007 Feb 19; 13(10):1039-52. PubMed ID: 17430167
    [Abstract] [Full Text] [Related]

  • 51. [Novel therapeutics for COPD].
    Hoshino Y, Muro S, Mishima M.
    Nihon Rinsho; 2011 Oct 19; 69(10):1826-30. PubMed ID: 22073581
    [Abstract] [Full Text] [Related]

  • 52. Strategies for chemokine antagonists as therapeutics.
    Proudfoot AE, Power CA, Rommel C, Wells TN.
    Semin Immunol; 2003 Feb 19; 15(1):57-65. PubMed ID: 12495641
    [Abstract] [Full Text] [Related]

  • 53. Chemokines and chemokine receptors in renal transplantation--from bench to bedside.
    Fischereder M.
    Acta Physiol Hung; 2007 Mar 19; 94(1-2):67-81. PubMed ID: 17444276
    [Abstract] [Full Text] [Related]

  • 54. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
    Barnes PJ.
    Pharmacol Rev; 2016 Jul 19; 68(3):788-815. PubMed ID: 27363440
    [Abstract] [Full Text] [Related]

  • 55. CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.
    Litsiou E, Semitekolou M, Galani IE, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, Andreakos E, Sideras P, Zakynthinos S, Tsoumakidou M.
    Am J Respir Crit Care Med; 2013 Jun 01; 187(11):1194-202. PubMed ID: 23525932
    [Abstract] [Full Text] [Related]

  • 56. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.
    Antoniu SA.
    Expert Opin Biol Ther; 2013 Feb 01; 13(2):257-68. PubMed ID: 23282002
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Prospects for new drugs for chronic obstructive pulmonary disease.
    Barnes PJ, Hansel TT.
    Lancet; 2013 Feb 01; 364(9438):985-96. PubMed ID: 15364192
    [Abstract] [Full Text] [Related]

  • 60. Current status of chemokine receptor inhibitors in development.
    Allegretti M, Cesta MC, Garin A, Proudfoot AE.
    Immunol Lett; 2012 Jul 30; 145(1-2):68-78. PubMed ID: 22698186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.